The direct cost of dialysis supported by families for patients with chronic renal failure in Ouagadougou (Burkina Faso)

Abstract

Background Chronic renal failure can lead to dialysis and/or a kidney transplant in the final stage. The number of patients under dialysis has increased considerably in the world and particularly in sub-Saharan Africa. Dialysis is a very expensive care. This is the reason why this study on the costs of dialysis management was initiated in Burkina Faso. The objective of the study is to determine the direct medical and non-medical costs of managing chronic renal failure among dialysis patients in Ouagadougou in 2020. Methods An analytical cross-sectional study was conducted. Data were collected in the hemodialysis department of three public university hospitals in Ouagadougou, Burkina Faso. All dialysis patients with chronic renal failure were included in the study. Linear regression was used to investigate the determinants of the direct medical and non-medical cost of hemodialysis. Results A total of 290 patients participated in this study, including children, adults, and the elderly with extremes of 12 and 82 years. Almost half of the patients (47.5%) had no income. The average monthly total direct cost across all patients was 75842 CFA or US$134.41.The average direct medical cost was 51315 CFA or US$90.94 and the average direct non-medical cost was 24 527 CFA or US$43.47. Most of the patients (45.2%) funded their hemodialysis by their own source. The multivariate analysis showed that the presence of an accompanying person during treatment, residing in a rural area, ambulatory care, use of personal cars, and treatment at the dialysis center of Yalgado Teaching Hospital were associated with higher direct costs. Conclusion The average cost of dialysis services borne by the patient and his family is very high in Burkina Faso, since it is 2.1 times higher than the country's minimum interprofessional wage (34664 CFA or US$61.4). It appears that the precariousness of the means of subsistence increases strongly with the onset of chronic renal failure requiring dialysis. Thus, to alleviate the expenses borne by dialysis patients, it would be important to extend the government subsidy scheme to the cost of drugs and to promote health insurance to ensure equitable care for these patients.

The cost of arteriovenous fistula placement in patients with chronic end-stage renal disease in Ouagadougou (Burkina Faso) 2020

“…The prevalence of AVF was over 90% in 2013 in Japan and Russia, in the USA it had increased from 24% to 68%, and in South Africa it was 51%. Studies have shown the cost of dialysis borne by patients and families [8,9]. According to the National Kidney Foundation, in the United States, Medicare spends an average of 90,000 USD per patient per year on hemodialysis treatment for CKD [10].…”

Quality of Life of Family Caregivers of Patients Undergoing Dialysis: A Literature Review

“…The impact of dialysis costs including costs of the dialysis process, medicine and transportation on patients and families is very high. The risk of dialysis irregularities is related to the costs incurred ( Toure et al, 2022 ). A previous study showed that the majority of 300 families in Iran who participated in the care of patients with CKD had a poor quality of life (QoL; Sajadi et al, 2021 ).…”

Willingness to pay for haemodialysis among patients with chronic kidney disease in Abuja, Nigeria

“…The economic burden of CKD on patients, providers, government, and society is high. ESKD patients in Nigeria and Burkina Faso face financial hardship from paying for haemodialysis at a cost two or more times higher than the country’s minimum wage [ 6 , 7 ]. The cost of managing CKD increases substantially with the disease severity [ 8 , 9 ].…”